Paper-Based Diagnostic Test Kit Market is Projected to Reach US$ 38.92 Billion by 2034 | Fact.MR Report

The global paper-based diagnostic test kit market is expected to reach a value of US$ 17.19 billion by 2024 and further grow at a CAGR of 8.5% to end up at US$ 38.92 billion by 2034.

It is estimated that with the rising cases of obesity and individuals shifting their lifestyle habits, including smoking and consuming unhealthful food, the incidence of lifestyle-related diseases, including diabetes and cardiovascular disease, will increase worldwide. For instance, as stated by the International Diabetes Federation (IDF), in 2021 there were about 540 million new cases of diabetes globally. Additionally, diabetes impacts 10.5% of the population aged between 20 and 79, and half of them are unaware of it. By 2045, IDF estimates that cases of diabetes will increase by 46% or 783 million individuals.

The industry has been propelled by increasing R&D spending of government agencies in the development of new in vitro diagnostics tools and tests. For instance, the European Diagnostic Manufacturers Association (EDMA) invests yearly in the R&D efforts of in vitro diagnostics. It is interested in the development and overall growth of the in vitro diagnostic industry in Europe.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=583

Key Takeaways from Market Study:

The Paper-Based Diagnostic Test Kit Market will grow from US$ 17.19 billion in 2024 to US$ 38.92 billion by 2034 at a CAGR of 8.5%.
East Asia will reach US$ 6.66 billion by 2034, driven by improved healthcare infrastructure.
North America will hold 34.3% of the market share by 2034, supported by technological advancements.
Covid Test Kits will be valued at US$ 13.7 billion by 2034 due to ongoing demand for testing solutions.
The United States will reach US$ 13.51 billion by 2034, driven by strong healthcare investments.

Leading Players Driving Innovation in the Paper-Based Diagnostic Test Kit Market:

Roche Diagnostics Limited; ARKRAY Inc.; Diagnostics For All Inc.; Kenosha Tapes; Abbott Laboratories Inc.; Beckman Coulter Inc.; Becton Dickinson and Company; Siemens AG; Alere Inc.; Johnson and Johnson; ACON laboratories; Bio-Rad laboratories; Abingdon Health; Chembio-diagnostic systems; Cytodiagnostics; Bioporto; Enzo Lifesciences Inc.; Imnora biosciences

Regional Analysis:

The United States continues to be among the prime markets for paper-based diagnostic test kits in the world. The growth of the market within the country is also facilitated by the initiatives of governments to enhance the diagnosis of contagious diseases. Market growth is triggered by several factors, including major players with extensive distribution channels in the United States.

Asia Pacific is likely to be a fast-growing region in the next five years. Infectious diseases such as tuberculosis and dengue are driving the fast growth of the region. Increasing fear of fatal diseases, including Ebola, in the Asia Pacific region is driving the growth of advanced healthcare systems.

According to a study, the largest number of TB cases were observed in Southeast Asia and Western Pacific. Most of the recent cases are reported from Indonesia, China, India, Pakistan, Bangladesh, South Africa, Nigeria, the Philippines, and Pakistan, South Africa, Bangladesh, and Nigeria.

Browse Full Report: https://www.factmr.com/report/583/paper-based-diagnostic-test-kits-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global paper-based diagnostic test kit market, presenting historical data for 2020 to 2024 and forecast statistics for 2024 to 2034.

The study reveals essential insights on the basis of the is segmented based on product type, end user, and region. By product type, the market includes Lateral Assay Test Kits, Dip Stick Kits, Microfluid Paper Kits, COVID Test Kits, Drugs Test Kits, Diabetes Test Kits, Food Quality Test Kits, and Other Diagnostic Kits, catering to various medical and non-medical applications. Based on end user, the key segments are Hospitals, Diagnostic Centers, and Home Care Settings, reflecting the widespread use of these test kits in professional and personal healthcare environments.

Geographically, the market is divided into North America, Western Europe, Eastern Europe, Latin America, East Asia, South Asia & Pacific, and the Middle East & Africa, with each region exhibiting distinct growth patterns influenced by healthcare infrastructure, technological advancements, and regulatory landscapes.

Check out More Related Studies Published by Fact.MR Research:

Sterile Vials Market- https://www.factmr.com/report/sterile-vials-market

Intraoral Scanners Market- https://www.factmr.com/report/intraoral-scanners-market

Imaging Agents Market- https://www.factmr.com/report/imaging-agents-market

Genetic Testing Services Market- https://www.factmr.com/report/4744/genetic-testing-services-market

Niacin and Niacinamide Market- https://www.factmr.com/report/4290/niacin-and-niacinamide-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.